Before changing the therapy regimen, researchers from the Mayo Clinic and UCSD said physicians should reassess the patient to determine whether the recurring symptoms are a results of Crohn’s disease or perhaps some other condition, such as enteric infection, concomitant IBS or depression.
They also suggest conducting CT or MR enterography before changing the treatment. If employing capsule endoscopy, physicians should be mindful of potential small-bowel obstruction that would require surgery, they said.
Read the news report about reassessing anti-TNF therapy for Crohn’s disease patients.
Read other coverage about GI studies:
– Diet Impacts Occurrence of Inflammatory Bowel Disease
– Johns Hopkins: Pediatric IBD Cases Growing, but Diagnosed Late
– Study: Patients Taking Isotretinoin at Increased Risk of Ulcerative Colitis
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
